DK1845093T3 - Ny krystallinsk og stabil form af andolast - Google Patents

Ny krystallinsk og stabil form af andolast

Info

Publication number
DK1845093T3
DK1845093T3 DK06112427T DK06112427T DK1845093T3 DK 1845093 T3 DK1845093 T3 DK 1845093T3 DK 06112427 T DK06112427 T DK 06112427T DK 06112427 T DK06112427 T DK 06112427T DK 1845093 T3 DK1845093 T3 DK 1845093T3
Authority
DK
Denmark
Prior art keywords
andolast
new crystalline
stable form
conditions
disodium
Prior art date
Application number
DK06112427T
Other languages
English (en)
Inventor
Antonio Giordani
Paolo Senin
Francesco Makovec
Walter Peris
Lucio Claudio Rovati
Antonino Santoro
Matteo Ghirri
Paola Gilotta
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of DK1845093T3 publication Critical patent/DK1845093T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
DK06112427T 2006-04-10 2006-04-10 Ny krystallinsk og stabil form af andolast DK1845093T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112427A EP1845093B1 (en) 2006-04-10 2006-04-10 A new crystalline and stable form of andolast

Publications (1)

Publication Number Publication Date
DK1845093T3 true DK1845093T3 (da) 2009-09-14

Family

ID=36942320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06112427T DK1845093T3 (da) 2006-04-10 2006-04-10 Ny krystallinsk og stabil form af andolast

Country Status (11)

Country Link
US (2) US7824710B2 (da)
EP (1) EP1845093B1 (da)
JP (1) JP5265876B2 (da)
AT (1) ATE433443T1 (da)
AU (1) AU2007200816B2 (da)
CA (1) CA2579333A1 (da)
DE (1) DE602006007211D1 (da)
DK (1) DK1845093T3 (da)
ES (1) ES2327265T3 (da)
PL (1) PL1845093T3 (da)
PT (1) PT1845093E (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7444197B2 (en) * 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
DE69722610T2 (de) * 1997-08-08 2004-04-29 Rotta Research Laboratorium S.P.A., Monza Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
DE602004015788D1 (de) 2004-08-19 2008-09-25 Rottapharm Spa Verwendung von Phenylbenzamide-derivaten zur Behandlung von chronisch-obstruktiver Lungenerkrankung (COPD)

Also Published As

Publication number Publication date
CA2579333A1 (en) 2007-10-10
JP2007277228A (ja) 2007-10-25
EP1845093B1 (en) 2009-06-10
US20110086896A1 (en) 2011-04-14
AU2007200816B2 (en) 2012-11-01
PT1845093E (pt) 2009-08-17
ES2327265T3 (es) 2009-10-27
EP1845093A1 (en) 2007-10-17
JP5265876B2 (ja) 2013-08-14
ATE433443T1 (de) 2009-06-15
AU2007200816A1 (en) 2007-10-25
PL1845093T3 (pl) 2009-11-30
US7824710B2 (en) 2010-11-02
DE602006007211D1 (de) 2009-07-23
US20070149586A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
ES2362788T3 (es) Compuesto de indolina y proceso para la producción del mismo.
ES2336287T3 (es) Modificaciones polimorficas de acido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazol-carboxilico, y procedimientos para su preparacion.
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
BR112017005410B1 (pt) Compostos de uracila contendo anel de isoxazolina e os usos dos mesmos
NO339021B1 (no) (S)-(-)-1-(4-fluorisokinolin-5-yl)-sulfonyl-2-metyl-1,4-homopiperazinhydrokloriddihydrat samt fremgangsmåte for fremstilling av samme
PT1542970E (pt) Derivados de pirrolidona como inibidores de maob
WO1999052525A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
NO20065441L (no) Fremgangsmate for fremstilling av atazanavir-bisulfat og nye varianter
ES2314593T3 (es) Forma cristalina alfa de ranelato de estroncio, su procedimiento de preparacion y composiciones farmaceuticas que la contienen.
Fini et al. Diclofenac salts, part 7: Are the pharmaceutical salts with aliphatic amines stable?
CY1107112T1 (el) Κρυσταλλοι τοζιλικου suplatast
PT2060568E (pt) Polimorfos de erdosteína enantiopura
PL1845093T3 (pl) Nowa krystaliczna i stabilna postać andolastu
PT1225174E (pt) Cristais de mirtazapina anidros e processo para a sua producao
BRPI0620527A2 (pt) polimorfo cristalino da forma i, polimorfo cristalino da forma ii, mistura de polimorfos da forma i e forma ii, processo para preparar um polimorfo cristalino da forma i, processo para preparar um polimorfo cristalino da forma ii, processo para preparar uma mistura de um polimorfo cristalino da forma i e da forma ii, composição para combater insetos, ácaros, fungos e bactérias, método para combater insetos, ácaros, fungos e bactérias, método para proteger colheitas de seres vivos nocivos, processo para preparar um composto de piridinamina, processo para purificar um composto, processo para preparar e purificar 3-cloro-n-(-3-cloro-5-trifluorometil-2-piridil)-a,a,a-t rifluoro-2, 6-dinitro-p-toluidina (fluazinam) e processo para preparar fluazinam
HUP0101230A2 (hu) Eljárás 2-[(2-piridil)-metilszulfinil]-1H-benzimidazol-származékok előállítására
CN101652358A (zh) 新型晶体贝他斯汀金属盐水合物、它的制备方法和包含它的药物组合物
ES2373738T3 (es) Método de preparación de derivados puros del 4-pirrolidinofenilbencil éter como inhibidores de la maob.
AR056721A1 (es) Preparado farmaceutico oral estabilizado que contiene clopidogrel bisulfato
Polenske et al. The binary phase diagram of propranolol hydrochloride and crystallization‐based enantioseparation
HRP20250341T1 (hr) Spoj, njegova farmaceutski prihvatljiva sol ili njegov optički izomer, postupak za njegovu proizvodnju, i farmaceutski pripravak za prevenciju ili liječenje virusnih bolesti, koji sadrži taj spoj kao aktivni sastojak
PE20010209A1 (es) Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas
US20220143186A1 (en) Solidification or crystallisation method
DE602006002738D1 (de) Verbessertes Verfahren zur Herstellung von Moxonidine
ES2441970T3 (es) Método para producir lansoprazol